news PANACEA consortium to increase global access to NMR spectroscopy 26 October 2021 | By Anna Begley (Drug Target Review) The Pan-European Solid-State NMR Infrastructure for Chemistry-Enabling Access will offer researchers access to over 30 NMR spectrometers.
news Automated method to produce synthetic DNA created 13 May 2021 | By Victoria Rees (Drug Target Review) Researchers have developed a technique to synthetically produce DNA oligonucleotides that avoids the degradation of phosphoramidites.
news Approved MS medication inhibits SARS-CoV-2 replication in vitro 5 October 2020 | By Hannah Balfour (Drug Target Review) Dimethyl fumarate (DMF), a multiple sclerosis (MS) drug, inhibited SARS-CoV-2 replication and the hyper-inflammatory immune response associated with COVID-19.
news Removing macrophages shows success against ovarian cancer in mice 27 March 2020 | By Victoria Rees (Drug Target Review) By removing two kinds of macrophages in mice, researchers showed that ovarian tumours in mice were reduced in size and stopped spreading.
news Study presents new ways of developing chronic inflammation treatment 2 September 2019 | By Rachael Harper (Drug Target Review) Researchers have found a new way to treat the inflammation involved in chronic diseases.
news Blocking specific macrophages leads to tumour shrinkage 28 August 2019 | By Victoria Rees (Drug Target Review) A study has found that removing a particular kind of macrophage enables the immune system to attack tumours, providing a potential drug target.
news The mysterious functions of the PCSK9 protein 3 January 2019 | By Drug Target Review Researchers have described the methods used to build a model of the 'druggable' PCSK9 inhibitor and detailed how it works...
news Novo Nordisk and Aarhus University team up for protein technology R&D 1 July 2016 | By Victoria White, Digital Content Producer Novo Nordisk and Aarhus University's Science and Technology faculty are to collaborate to strengthen protein technology research and development...